The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Professor of Vascular Pharmacology, University of Oxford and Fellow and Tutor in Medicine, Magdalen College, Oxford. Visiting Professor at the University of Queensland, Australia. Previously, Head and Professor of Pharmacology, University of Bath and Professor of Cardiovascular Pharmacology, University of Bristol. Visiting Professorships; University of Nagoya, Japan, Monash University, Australia and the National Academy of Sciences, Taiwan.
Dr. Agrawal is a Professor of Earth & Environmental Sciences, Wright State University. In the past, he served as Director of Graduate Programs, and Associate Chair, in Earth & Environmental Sciences dept., Wright State University.
Dr. Agrawal has been visiting professors/scholars at Miami University, Oxford, Ohio (2014); School of Earth Sciences, Ohio State University, Columbus, Ohio (2013); Johns Hopkins University, Baltimore, MD (2004); Center for Higher Learning, NASA’s Stennis Space Center, MS (2003). Prior to his appointment at Wright State University in 1995, he worked as a post-doctoral Research Associate at the Oak Ridge National Laboratory (1995), and a Fellow of the National Science and Engineering Research Council, Canada (1994-95).
Dr. Agrawal has presented invited talks at the numerous national and international academic institutions, which include Indian Institute of Technology Madras, Chennai, India (2017); Ministry of Human Resource and Development of the Gov’t of India (2016); Harbin Institute of Technology, State Key Laboratory of Urban Water Resources and Environment, Harbin, P.R. China (2015); Indian Institute of Technology, Roorkee, India (2014); School of Earth Sciences, Ohio State University (2014), etc. In Spring 2016, Dr. Agrawal organized a symposium titled 'Advances in In-situ Pollutant Destruction by Nanoscale Zero-Valent Iron & Other Engineered Nanoparticles' at the 251st American Chemical Society Annual Meeting in San Diego.
Fabiana Perocchi is an Emmy Noether Group Leader at the Helmholtz Zentrum München and Munich University. She trained as a postdoc with Vamsi Mootha at MGH and Harvard Medical School. She has a PhD in Functional Genomics from EMBL (European Molecular Biology Laboratory) and Heidelberg University, with Prof. Lars Steinmetz. Her research seeks to understand the signaling cascades that regulate mitochondrial metabolism and calcium homeostasis and their dysfunctions in neurodegenerative diseases.
Dr. Cancedda graduated in Medicinal Chemistry at the University of Genoa in 1999, with a thesis on the role of neurotrophic factors on neurotransmitter release. She received her Ph.D. in neurophysiology from Scuola Normale Superiore in 2003, under the supervision of Dr. Lamberto Maffei. In Pisa, she investigated the molecular and environmental basis of experience-dependent plasticity in the rat brain. In 2003, she moved to University of California at Berkeley in Dr. Poo’s laboratory where she focused on molecular mechanisms of GABAergic-transmission modulation. Starting in 2006, she has also started a collaboration on a project aimed at studying early determinants of neuronal polarization.
Currently, she holds a team-leader position at the Italian Institute of Technology (IIT) in Genoa and a scientist position at the Telethon Dulbecco Institute. Laura is also a scholar of the FENS KAVLI network of excellence. Her research focuses on the role of extracellular factors such as GABA in neurogenesis, migration and morphological maturation of cortical neurons under physiological as well as pathological conditions.
Situated at the interface of microbial ecology, bioinformatics, and biostatistics, my research group is dedicated to the study of the structure and function of mixed microbial communities. Our work includes the study of the human microbiome and microbiome-environment interactions, as well as the development and improvement of bioinformatics approaches for microbiome analysis. I am an assistant professor in the Department of Pathology & Immunology at Baylor College of Medicine and serve as the Director of Microbial Ecology for the Texas Children's Microbiome Center at Texas Children's Hospital.
I earned a PhD in development working with Drosophila in Ginés Morata laboratory in Madrid and later moved to flower development using another model system, Arabidopsis, in the Marty Yanofsky laboratory at UCSD, La Jolla, CA. Currently, I am an ICREA Research Professor at CRAG (Centre for Research in Agricultural Genomics) located in Barcelona, Spain. I am very interested in the control of flowering and how other plant developmental processes are regulated by my favorite genes, TEMPRANILLO.
Emmy Noether research group leader, Albert-Ludwigs-Universität Freiburg, Germany
Emmy Noether research group leader, Ludwig Maximilians University, Munich, Germany
Postdoc, Department of Molecular and Cell Biology, UC Berkeley, USA
PhD in Biology, Max Planck Institute of Molecular Cell Biology and Genetics Dresden, Germany
Assistant Professor in the Department of Psychiatry at the University of California San Diego, USA. Currently investigates the molecular basis of neurodevelopmental and psychiatric diseases using genomic and systems biology approaches.
Dr. Iakoucheva’s research focuses on understanding of the molecular basis of autism and schizophrenia using systems biology approaches. The aim is to discover functional protein interaction networks connecting seemingly unrelated candidate genes for psychiatric diseases. Dr. Iakoucheva’s lab is building comprehensive protein-protein interaction networks for autism and schizophrenia candidate genes and their splicing isoforms. In addition, they are integrating gene expression data with our experimentally derived networks to understand spatio-temporal dynamics of protein interactions in the brain. Their immediate goal is to investigate perturbations of the disease networks by the Copy Number Variants (CNVs) and protein-damaging Single Nucleotide Variants (SNVs) identified in the patients using the Whole Exome Sequencing (WES) studies. Additionally, they are interested in interpreting non-coding genetic variation with relevance to psychiatric diseases. They are investigating functional impact of UTR, promoter and splice site mutations identified in the Whole Genome Sequencing (WGS) studies of autism and schizophrenia using in vitro cellular systems.
Anders J. Hansen (AJH) has extensive experience working with characterization of genetic material in difficult samples either being aDNA, eDNA, forensic genetics or degraded DNA. AJH was one for the first to use DNA technology to characterize species contents in ancient environmental samples like ice and permafrost. Currently AJH’s research interests predominant focus on forensic genetics as well as genetic identification and discovery by metagenomic analysis of DNA and RNA in complex tissue samples, recent and ancient sediments including permafrost with the aim of describing the composition, regulation and distribution of genes, microorganism, phage’s, viruses and more.
I research the carbon dynamics of peatlands. Specifically this addresses the impact of climate change on the functioning of the ecosystem, greenhouse gas emissions and vegetation.
Associate Professor at the Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary. Research Associate at the Department of Anesthesiology, University of Maryland, Baltimore, MD, USA during 2004. Academic Fellow at the Department of Anesthesiology, University of Maryland, Baltimore, MD, USA during 2002-2003. Primary field of interest: Bioenergetics, Mitochondriology.
Graduated in Medicine in 1988 at the University of Padua. Pediatrician in 1992. I have been actively involved in pediatric hematology and oncology, especially in chemotherapy for leukemia and lymphoma, supportive care, and early and late effects of treatment, and hematopoietic stem cell transplantation (HSCT).
Appointed in 2009 Director of the Pediatric Hematology and Oncology Unit at the Department of Pediatrics in Verona. Member of the scientific committees of several working groups including Pediatrics (for MASCC), Supportive Care (for SIOP), Aplastic Anemia, Infection (for EBMT), hematopoietic stem cell transplant, Infection, Supportive care (for AIEOP). Appointed in 2005 and 2015 Chairman of the Supportive Care Group and Infection of AIEOP (Italian Association of Pediatric Hematology Oncology), respectively. Appointed in 2010, Chairman of Infectious Diseases Working Party of European Society for Blood and Marrow Transplantation.
Author of more than 200 publications in peer-reviewed journals. Medical advisor of the charities Paul O’Gorman Lifeline (UK) and Lifeline Italia, liaising with and advising pediatric hematology and oncology centers in Russia, Ukraine, Georgia and Kyrgyzstan.